Future challenges for health economics and health technology assessment of biological drugs

European Journal of Health Economics

Volumn 11, Issue 3, 2010, Pages 235-238

  Gulá, László ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; BIOLOGICAL PRODUCT;

ANKYLOSING SPONDYLITIS; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL TRIAL; EDITORIAL; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; STRUCTURED QUESTIONNAIRE; TREATMENT OUTCOME; COST; ECONOMICS; INCIDENCE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RHEUMATIC DISEASE;

BIOLOGICAL PRODUCTS; COSTS AND COST ANALYSIS; HUMANS; INCIDENCE; PATIENT COMPLIANCE; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RHEUMATIC DISEASES; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 77954504898     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-010-0246-2     Document Type: Editorial

References (8)

1. Bobak M.: CEE countries; Data availability and methodological issues. Eurohealth 15(3):14-16
2. Boncz, I., Brodszky, V., Péntek, M., A ́ goston, I., Nagy, Z.S., Kárpáti, K., Kriszbacher, K., Fuszek, P., Gulácsi, L.: The disease burden of colorectal cancer in Hungary. Eur. J. Health Econ. 10(1), S35-S40 (2010)
3. Gulácsi, L., Boncz, I., Drummond, M.: Issues for countries considering introducing the fourth hurdle: the case of Hungary. Int. J. Technol. Assess. Health Care 20(2), 1-5 (2004)
4. Gulácsi, L., Brodszky, V., Péntek, M., Varga, S., Vas, G., Boncz, I.: History of health technology assessment in Hungary. Int. J. Technol. Assess Health Care. Jul;25 Suppl 1:120-126 (2009)
5. Harrold, L.R., Andrade, S.E.: Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature. Semin. Arthritis Rheum. 38(5), 396-402 (2009)
6. Jönsson, B.: Time for a common standard for cost-effectiveness. Eur. J. Health Econ. 7, 223-224 (2006)
7. Kobelt, G., Jönsson, B.: The burden of rheumatoid arthritis and access to treatment: outcome and cost-utility of treatments. Eur. J. Health Econ. 8(Suppl 2), 95-106 (2008)
8. Lundkvist, J., Kastang, F., Kobelt, G.: The burden of rheumatoid arthritis and access to treatment: health burden and costs. Eur. J. Health Econ. 8(Suppl 2), S49-60 (2008)